logo

For the Inventor, By the Inventor

Vienna, Austria

Stefan Welzig

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Wien, AT (2018)
  • Vienna, AT (2007 - 2019)

Company Filing History:

goldMedal13 out of 15 
 
Sanochemia Pharmazeutika Ag
 patents

Years Active: 2007-2019

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 10265397 - Formulation for photodynamic therapy (2019-04-23),
2. 10201609 - Method for the production of a formulation of a hypericin salt (2019-02-12),
3. 10143751 - Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof (2018-12-04),
4. 10064961 - Method for producing a liquid pharmaceutical preparation (2018-09-04),
5. 9775900 - Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof (2017-10-03),
6. 9675598 - Compositions of tolperisone (2017-06-13),
7. 9662317 - Methods of administering tolperisone for therapeutic purposes (2017-05-30),
8. 9629932 - Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof (2017-04-25),
9. 9315480 - Compositions of tolperisone (2016-04-19),
10. 8372979 - Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone (2013-02-12),
11. 8212029 - Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6H-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof (2012-07-03),
12. 7385060 - Method for producing salts of tolperisone (2008-06-10),
13. 7166588 - Derivatives and analogs of galanthamine (2007-01-23),

Title: The Innovations of Stefan Welzig

Introduction

Stefan Welzig is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of photodynamic therapy, particularly in the treatment of tumors. With a total of 13 patents to his name, Welzig's work is recognized for its innovative approaches and practical applications in medicine.

Latest Patents

Among his latest patents, Welzig has developed formulations for photodynamic therapy targeting tumors, such as bladder tumors. His innovative approach involves the use of a photosensitizer that is a complex or compound of hypericin and a polymeric complexing agent. The photosensitizer is created from an alkali salt of hypericin, which can be either a sodium salt or a potassium salt, combined with a complexing agent like polyethylene glycol or poly-N-vinyl amide. This formulation aims to enhance the effectiveness of photodynamic therapy in treating various tumors.

Career Highlights

Welzig's career is marked by his dedication to advancing medical treatments through innovative research. He is currently associated with Sanochemia Pharmazeutika AG, where he continues to develop groundbreaking therapies. His work has not only contributed to the scientific community but has also provided new hope for patients suffering from challenging medical conditions.

Collaborations

Stefan Welzig collaborates with notable colleagues, including Klaus Gerdes and Jan Rothenburger. These partnerships enhance the research and development process, allowing for a more comprehensive approach to innovation in the medical field.

Conclusion

Stefan Welzig's contributions to photodynamic therapy exemplify the impact of innovation in medicine. His patents and ongoing research continue to pave the way for new treatment options, showcasing the importance of creativity and collaboration in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…